Dr Agarwals Health Care Share Price

Dr Agarwals Health Care Limited was incorporated as Dr. Agarwals Health Care Limited pursuant to Certificate of Incorporation dated April 19, 2010, issued by the Registrar of Companies, Tamil Nadu at Chennai and commenced operations pursuant to Certificate for Commencement of Business dated May 29, 2010, issued by the RoC.The Company provide eye care services and products, covering cataract surgeries, refractive treatments and other surgeries and services such as consultations, clinical investigations and diagnoses and nonsurgical treatments and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer surgeries for multiple eye ailments, including cataract, corneal, retinal, and refractive, and other surgeries. It provide other treatments, including glaucoma treatments, squint treatments, and oculoplasty surgeries, among others. Some of the key surgical capabilities include intraocular lens procedures, cornea transplantation, pinhole pupilloplasty, single pass fourthrow pupilloplasty and LASIK surgeries.The Company had set up eye clinics by entering into Telangana and Karnataka markets during the year 2010. In 2012, it entered the Africa market with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique. In addition to operations in India, the Company commenced international operations in 2012, which presently operate 15 Facilities in Africa, where it provide a range of eye care services, including treatments for cataract, glaucoma, diabetic retinopathy, retinal detachment, and dry eye, along with refractive surgeries, and paediatric and neuro ophthalmological.Further, the Company acquired hospitals in Maharashtra in 2017. It launched the 100th eye care facility in 2021 further it strengthened the Gujarat market by acquiring the eye care business in 2022 acquired Punjab Eye Hospital in 2023 acquired an eye care business in Varanasi, Uttar Pradesh and acquired Dr Thind Eye Care Private Limited in Punjab in 2024.The Company raised funds of Rs 3027.26 Cr through IPO by issuing an aggregate of 75,304,970 equity shares of face value of Re 1, comprising a fresh issue of 7,462,686 equity shares amounting to Rs 300 Cr and the offer for sale of 67,842,284 equity shares amounting to Rs 2727.26 Cr in January 2025. During the year 2025, Company has opened 31 new primary centres during the year. On May 27, 2025, the Company expanded its operations, by opening the first eye care facility in the NCR, New Delhi.

Dr Agarwals Health Care reported a Q1 FY 2025-26 revenue of ₹487.42 crore, up 27.6% YoY, with net profit increased 16.1% to ₹38.06 crore. For the full year FY2025–2026, revenue reached ₹1757.02 crore and profit touched at ₹110.34 crore. As of Sep '25, Dr Agarwals Health Care’s market capitalisation stood at ₹16,446.56 crores. Shareholding as of Sep '25 shows promoters holding 32.4%, with FIIs at 58.1%, DIIs at 7.9%, and public at 1.5%.

As of 14 Oct 2025, Dr Agarwals Health Care share price is ₹520.2. The stock opened at ₹516.5 and had closed at ₹519.4 the previous day. During today’s trading session, Dr Agarwals Health Care share price moved between ₹511.95 and ₹526.40, with an average price for the day of ₹519.17. Over the last 52 weeks, the stock has recorded a low of ₹327.00 and a high of ₹543.20. In terms of performance, Dr Agarwals Health Care share price has increased by 25.3% over the past six months and has increased by 14.52% over the last year.